Familial motor neuron disease: co-occurrence of PLS and ALS (-FTD)

References

• Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, et al. Primary lateral sclerosis: Consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91:373–7.
   PubMed Web of Science ®Google Scholar
• de Vries BS, Spreij LA, Rustemeijer LMM, Bakker LA, Veldink JH, van den Berg LH, et al. A neuropsychological and behavioral study of PLS. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:376–84.
   PubMed Web of Science ®Google Scholar
• de Vries BS, Rustemeijer LMM, van der Kooi AJ, Raaphorst J, Schröder CD, Nijboer TCW, et al. A case series of PLS patients with frontotemporal dementia and overview of the literature. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:534–48.
   PubMed Web of Science ®Google Scholar
• Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Pract Neurol. 2020;20:262–9.
   PubMedGoogle Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495–520.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Erfanian Omidvar M, Torkamandi S, Rezaei S, Alipoor B, Omrani MD, Darvish H, et al. Genotype–phenotype associations in hereditary spastic paraplegia: a systematic review and meta-analysis on 13,570 patients. J Neurol. 2021;268:2065–82.
   PubMed Web of Science ®Google Scholar
• Mereaux JL, Banneau G, Papin M, Coarelli G, Valter R, Raymond L, et al. Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia. Brain. 2022;145:1029–37.
   PubMed Web of Science ®Google Scholar
• Huisman MHB, De Jong SW, Van Doormaal PTC, Weinreich SS, Schelhaas HJ, Van Der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
   PubMed Web of Science ®Google Scholar
• Van Rheenen W, Van Blitterswijk M, Huisman MHB, Vlam L, Van Doormaal PTC, Seelen M, et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 2012;79:878–82.
   PubMed Web of Science ®Google Scholar
• de Boer EMJ, de Vries BS, Pennings M, Kamsteeg EJ, Veldink JH, van den Berg LH, et al. Genetic characterization of primary lateral sclerosis. J Neurol. 2023;270:3970–80.
   PubMedGoogle Scholar
• Liu AJ, Chang JE, Naasan G, Boxer AL, Miller BL, Spina S. Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity. Neurocase. 2020;26:91–7.
   PubMed Web of Science ®Google Scholar
• Pasquini J, Trogu F, Morelli C, Poletti B, Girotti F, Peverelli S, et al. Parkinsonian syndromes in motor neuron disease: a clinical study. Front Aging Neurosci. 2022;14:917706.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Brugman F, Wokke JHJ, De Jong JMBV, Franssen H, Faber CG, Van Den Berg LH. Primary lateral sclerosis as a phenotypic manifestation of familial ALS. Neurology 2005;64:1778–9.
   PubMed Web of Science ®Google Scholar
• Corcia P, Lunetta C, Couratier P, Vourc’h P, Gromicho M, Desnuelle C, et al. Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: supplementary evidence for a continuum. Eur J Neurol. 2021;28:2780–3.
   PubMed Web of Science ®Google Scholar
• Dupre N, Valdmanis PN, Bouchard JP, Rouleau GA. Autosomal dominant primary lateral sclerosis. Neurology 2007;68:1156–7.
   PubMed Web of Science ®Google Scholar
• Gkazi SA, Troakes C, Topp S, Miller JW, Vance CA, Sreedharan J, et al. Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia. Neurobiol Aging. 2019;73:229.e5-229–e9.
   Web of Science ®Google Scholar
• Liu Y, Xu J, Tao W, Fu C, Liu J, Yu R, et al. Exome sequencing identifies a mutation (Y740C) in spastic paraplegia 7 gene associated with adult-onset primary lateral sclerosis in a Chinese family. Eur Neurol. 2019;81:87–93.
   PubMed Web of Science ®Google Scholar
• Praline J, Guennoc A-M, Vourc’h P, De Toffol B, Corcia P. Primary lateral sclerosis may occur within familial amyotrophic lateral sclerosis pedigrees. Amyotrophic Lateral Sclerosis. 2010;11:154–6.
   PubMed Web of Science ®Google Scholar
• Teyssou E, Chartier L, Amador M-D-M, Lam R, Lautrette G, Nicol M, et al. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis. Neurobiol Aging. 2017;58:239.e11-239–e20.
   Web of Science ®Google Scholar
• Vázquez-Costa JF, Payá-Montes M, Martínez-Molina M, Jaijo T, Szymanski J, Mazón M, et al. Presenilin-1 mutations are a cause of primary lateral sclerosis-like syndrome. Front Mol Neurosci. 2021;14:721047.
   PubMed Web of Science ®Google Scholar
• Vengoechea J, David MP, Yaghi SR, Carpenter L, Rudnicki SA. Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:615–9.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang L, Lynch DR, Lukas T, Ahmeti K, Sleiman PMA, et al. Compound heterozygote mutations in SPG7 in a family with adult-onset primary lateral sclerosis. Neurol Genet. 2016;2:e60.
   PubMed Web of Science ®Google Scholar
• Gómez-Tortosa E, Van Der Zee J, Ruggiero M, Gijselinck I, Esteban-Pérez J, García-Redondo A, et al. Familial primary lateral sclerosis or dementia associated with Arg573Gly TBK1 mutation. J Neurol Neurosurg Psychiatry. 2017;88:996–7.
   PubMed Web of Science ®Google Scholar
• Hirsch-Reinshagen V, Alfaify OA, Hsiung GYR, Pottier C, Baker M, Perkerson RB, et al. Clinicopathologic correlations in a family with a TBK1 mutation presenting as primary progressive aphasia and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:568–75.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Briemberg H. TDP-43 pathology in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020; 21:47–51.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:133–45.
   PubMed Web of Science ®Google Scholar
• Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919–31.
   PubMed Web of Science ®Google Scholar
• Zhou SL, Tan CC, Hou XH, Cao XP, Tan L, Yu JT. TREM2 variants and neurodegenerative diseases: a systematic review and meta-analysis. J Alzheimers Dis. 2019;68:1171–84.
   PubMed Web of Science ®Google Scholar
• Bagaria J, Bagyinszky E, An SSA. Genetics, functions, and clinical impact of presenilin-1 (PSEN1) gene. Int J Mol Sci 2022;23:Vol.
   Web of Science ®Google Scholar
• Schüle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016; Apr 179:646–58.
   PubMed Web of Science ®Google Scholar
• de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum. 2017;16:525–51.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Nagy PL, Gennings C, Murphy J, Andrews H, Goetz R, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015;1:e3.
   PubMed Web of Science ®Google Scholar
• Leighton DJ, Ansari M, Newton J, Parry D, Cleary E, Colville S, et al. Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland. J Neurol. 2023;270:1702–12.
   PubMed Web of Science ®Google Scholar